Hello,
In this June edition of the newsletter, I will provide details of the most recent and impactful NIH policy changes, our institutional submissions, office updates, sponsor updates, internal forms changes, system updates and proposal reminders.
Application Breakdown
Applications numbers have been analyzed for January 1 – June 30, 2025. OGS has already reviewed 612 applications (496 New, 23 Renewal, 81 Resubmission, 12 Supplement). The total cost request is $791,507,356. These applications were submitted by 58 Departments/Divisions across the institution.
The funding breakdown: 46% Federal prime, 26% Federal and Non-Federal subcontracts, 22% Non-Federal prime, 4% Industry, and >1% New York State and > 1% International. We are currently reviewing 35 applications.
Einstein leadership is reviewing the impact of executive orders and terminations of NIH grant awards. If you receive notice that your grant will be impacted or the parent award of a subcontract will be terminated, please contact Research Finance.
NIH policy changes are being released at a very unusual cadence, please see the list below for the most recent impactful changes:
NOT-OD-25-114 Notice of Short-Term Extension to Early-Stage Investigator (ESI) Eligibility Period
NOT-OD-25-115 Notice of Temporary Policy Exception to NIH Grants Policy Statement (NIHGPS) Section 12.3.7 to Permit Continued Eligibility for Mentored Career Development Award When an Award Ended Early
NOT-OD-25-124 Notice of Rescission of Civil Rights Term and Condition of Award
NOT-OD-25-127 Implementation Update: Terminating or Suspending Dangerous Gain-of-Function Research in Accordance with the Executive Order on Improving the Safety and Security of Biological Research
OGS Office Updates and Reminders
We are recruiting for the role of Senior Grant Specialist and the role of Grant Specialist in OGS. Come join our team!
Resource - Funding: OGS maintains an active license with SPINPlus portal. This portal has over 40,000 funding opportunities and allows investigators to set filters and receive notifications from the system of new field specific opportunities as they become available. Registration link for July 10th
Reminder - Communication: Please ensure that communication and sponsor required clarifications route through OGS. As the Authorized Organization Representatives (AOR), we will review, provide feedback, and offer our concurrence for all direct sponsor communications.
ProposalCentral: If you are submitting using ProposalCentral and you require institutional signature, you need to list the appropriate central office staff and provide edit access for the collection of signatures. All ProposalCentral full applications require an approved Cayuse record.
Federal Applications (424) Division: SF424 R&R page 1 “Person to be contacted on matters involving this application” list administrator information or Indranil Basu or Morgan McKenna. If you are submitting a DoD application list only OGS contact. SF424 R&R page 2 section for Authorized Representative please list Indranil Basu or Morgan McKenna. Applicant information and all sections with a field for the division must enter “Albert Einstein College of Medicine.”
Submission Policy Clarification (Enforcement): OGS requires the routing of proposals 8 business days prior to deadline for administrative documents. This includes the final budget, justification(s), Data Management and Sharing Plan (if applicable), biosketch of all key personnel, subcontract documents (signed SOI, performance site, biosketch of key persons, budget, and justification). If complete, you can also upload the Facilities and Other Resources, Equipment, Key Authentication, Vertebrate animal documents and the Protection of Human Subjects and study record documents.
We request the upload of final science 2 days prior to deadline (NIH recommendation).
Late Submission: OGS will require department, division or deans’ office approval for late submission review requests. This will be in the form of an email to the Chair of the department, Division Chief or the Executive dean requesting approval for late review.
Reminder - Routing: All Cayuse applications require full routing and budget approval prior to submission to sponsors.
Reminder – New Sponsors: If you plan to work with a new sponsor, it is important that OGS review contract and/or award terms. Please route language to OGS prior to submission.
Reminder (Holiday or Office Closure): OGS will have coverage for urgent signatures and application deadline support. Please be proactive and route applications and signature requests to OGS in advance.
Federal Sponsor Updates and Resources
NIH Updates:
Funding Opportunities updated March 31st. Please read all funding opportunities very closely for changes in requirements and language. Changes have been made to align with administrative priorities.
Common Forms - POSTPONED - Adoption for Biographical Sketch and Current and Pending (Other Support). All investigators will continue to use NIH-specific format pages until further notice. NSF is using SciENcv common forms (change live 5/20/2024).
NIH RePORTER Updates – If you want to adjust public facing information on RePORTER, we suggest that you contact your PO prior to routing the requested change to OGS for further guidance and discussion of your proposed changes.
Peer Review – Simplified Review Framework for NIH Research Project Grant Applications (NOT-OD-24-010). Resources for Simplified Review Framework webinar and overview of changes are available here.
Data Management and Sharing Plan (DMSP): OGS is not involved in the implementation of the DMSP. Please do not list OGS, RF, or any other central office on Element 6 of the plan, as this should be project personnel.
NIH Withdrawal: Avoid NIH administrative withdrawal of your application by communicating with the listed contact of the preferred agency in advance. This is recommended for all opportunities with limited agency involvement.
Please continue to reach out to OGS for all your research administrative related inquiries. We look forward to continuing to provide a high level of support for your applications as well as clear updates on sponsor’s requirements and guidance to maximize funding success!
Sincerely,
M. Caitlin McKenna